Skip to content

Home
About Us
- Board of Directors
- Management Team
Technology
News/Resources
Investor Centre
Contacts

ASX Announcements 2010

24 Dec 2010
Options
23 Dec 2010
Biotron Limited Security Trading Policy
26 Nov 2010
Results of Annual General Meeting
25 Nov 2010
International Study Supports Biotron’s HIV Drug Approach
11 Nov 2010
Presentation to investors
27 Oct 2010
Quarterly Report 30 September 2010
27 Oct 2010
Annual Report for year ended 30 June 2010 and Notice of Annual General Meeting
20 Oct 2010
Presentation to investors
14 Oct 2010
October 2010 edition of BITNews
1 Oct 2010
Phase II HCV Clinical Trial Commenced
31 Aug 2010
Year End Accounts and Preliminary Final Report for year ended 30 June 2010
11 Aug 2010
Quarterly Report 30 June 2010
23 Jul 2010
Presentation at International AIDS Conference
30 Jun 2010
June 2010 edition of BITNews
25 May 2010
Issue of Shares
19 May 2010
Change of Director’s Interest Notice
30 Apr 2010
Appointment of a Director
22 Apr 2010
Quarterly Report 31 March 2010
1 Apr 2010
Director Resignation
19 Mar 2010
Shareholder Update and Piggy Back Options Opportunity
18 Mar 2010
Biotron HCV Drug: International Partner to Progress Trial
26 Feb 2010
Half-year report 31 December 2009
5 Feb 2010
Allotment and Distribution of New Options
27 Jan 2010
Quarterly Report 31 December 2009
22 Jan 2010
Change of Director’s Interest Notice
15 Jan 2010
Entitlement Issue 23% Oversubscribed

<<
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
>>

Investor Centre

Investor Centre

© Biotron Limited 2016 ABN 60 086 399 144 Site updated 6 February 2020 Legal Notices and Privacy